Development of a green synchronous spectrofluorimetric technique for simultaneous determination of Montelukast Sodium and Bilastine in Pharmaceutical Formulations
For the treatment of rhinitis and asthma, a combination of Montelukast sodium and Bilastine has just been approved. Based on the first derivative of synchronous fluorescence, the current work developed a green, highly accurate, sensitive, and selective spectroscopic approach for estimating Montelukast sodium and Bilastine in pharmaceutical dosage form without previous separation. The selected technique focuses on measuring the synchronized ... إقراء المزيد